246 related articles for article (PubMed ID: 35711841)
1. Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer.
Shao G; Qian Y; Lu L; Liu Y; Wu T; Ji G; Xu H
J Cancer; 2022; 13(8):2430-2439. PubMed ID: 35711841
[TBL] [Abstract][Full Text] [Related]
2. Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).
Wang J; Li J; Fu Y; Zhu Y; Lin L; Li Y
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38362962
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.
Li Z; Jiang H; Ding T; Lou C; Bui HH; Kuo MS; Jiang XC
Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.
Zhao Y; Chen YQ; Bonacci TM; Bredt DS; Li S; Bensch WR; Moller DE; Kowala M; Konrad RJ; Cao G
J Biol Chem; 2008 Mar; 283(13):8258-65. PubMed ID: 18195019
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Lysophosphatidylcholine Acyltransferase 3 Deficiency-Mediated Inflammation Is Not Sufficient to Induce Atherosclerosis in a Mouse Model.
Jiang H; Li Z; Huan C; Jiang XC
Front Cardiovasc Med; 2018; 5():192. PubMed ID: 30705887
[TBL] [Abstract][Full Text] [Related]
6. Phospholipid Remodeling in Physiology and Disease.
Wang B; Tontonoz P
Annu Rev Physiol; 2019 Feb; 81():165-188. PubMed ID: 30379616
[TBL] [Abstract][Full Text] [Related]
7. Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis.
Tian Y; Jellinek MJ; Mehta K; Seok SM; Kuo SH; Lu W; Shi R; Lee R; Lau GW; Kemper JK; Zhang K; Ford DA; Wang B
Hepatology; 2024 Apr; 79(4):882-897. PubMed ID: 36999536
[TBL] [Abstract][Full Text] [Related]
8. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
Singh AB; Liu J
J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression.
Tanaka H; Zaima N; Sasaki T; Yamamoto N; Inuzuka K; Yata T; Iwaki T; Umemura K; Sano H; Suzuki Y; Urano T; Setou M; Unno N
J Vasc Res; 2017; 54(4):200-208. PubMed ID: 28683445
[TBL] [Abstract][Full Text] [Related]
10. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet.
Bourgeois T; Jalil A; Thomas C; Magnani C; Le Guern N; Gautier T; Pais de Barros JP; Bergas V; Choubley H; Mazzeo L; Menegaut L; Josiane Lebrun L; Van Dongen K; Xolin M; Jourdan T; Buch C; Labbé J; Saas P; Lagrost L; Masson D; Grober J
J Lipid Res; 2021; 62():100013. PubMed ID: 33518513
[TBL] [Abstract][Full Text] [Related]
11. Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.
Ishibashi M; Varin A; Filomenko R; Lopez T; Athias A; Gambert P; Blache D; Thomas C; Gautier T; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1171-9. PubMed ID: 23580142
[TBL] [Abstract][Full Text] [Related]
12. A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.
Du X; Hu J; Zhang Q; Liu Q; Xiang X; Dong J; Lou B; He S; Gu X; Cao Y; Li Y; Ding T
FEBS Open Bio; 2019 Oct; 9(10):1734-1743. PubMed ID: 31376210
[TBL] [Abstract][Full Text] [Related]
13. Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism.
Kabir I; Li Z; Bui HH; Kuo MS; Gao G; Jiang XC
J Biol Chem; 2016 Apr; 291(14):7651-60. PubMed ID: 26828064
[TBL] [Abstract][Full Text] [Related]
14. Essential Role of Lysophosphatidylcholine Acyltransferase 3 in the Induction of Macrophage Polarization in PMA-Treated U937 Cells.
Taniguchi K; Hikiji H; Okinaga T; Hashidate-Yoshida T; Shindou H; Ariyoshi W; Shimizu T; Tominaga K; Nishihara T
J Cell Biochem; 2015 Dec; 116(12):2840-8. PubMed ID: 25994902
[TBL] [Abstract][Full Text] [Related]
15. Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.
Kakisaka K; Suzuki Y; Fujiwara Y; Suzuki A; Kanazawa J; Takikawa Y
J Gastroenterol Hepatol; 2019 Jul; 34(7):1256-1262. PubMed ID: 30160786
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity.
He M; Li Z; Tung VSK; Pan M; Han X; Evgrafov O; Jiang XC
Diabetes; 2023 Nov; 72(11):1547-1559. PubMed ID: 37625119
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.
Li Z; Ding T; Pan X; Li Y; Li R; Sanders PE; Kuo MS; Hussain MM; Cao G; Jiang XC
J Biol Chem; 2012 Jun; 287(24):20122-31. PubMed ID: 22511767
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway.
Feng C; Lou B; Dong J; Li Z; Chen Y; Li Y; Zhang X; Jiang XC; Ding T
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):834-843. PubMed ID: 29673706
[TBL] [Abstract][Full Text] [Related]
19. LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis.
Thomas C; Jalil A; Magnani C; Ishibashi M; Queré R; Bourgeois T; Bergas V; Ménégaut L; Patoli D; Le Guern N; Labbé J; Gautier T; de Barros JPP; Lagrost L; Masson D
Atherosclerosis; 2018 Aug; 275():409-418. PubMed ID: 29866392
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice.
Cash JG; Hui DY
Nutr Diabetes; 2016 Apr; 6(4):e206. PubMed ID: 27110687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
